Published in Medical Devices and Surgical Technology Week, November 28th, 2004
Earnings per diluted share were 31 cents versus 28 cents last year. Sales for the quarter increased 4% to $80.3 million from $77.1 million last year, with foreign exchange contributing $1.2 million of the increase.
The increase in first-quarter earnings was primarily attributable to increased sales and a higher gross profit margin. Research and development expenses increased 20% to $8.6 million in the first quarter this year compared to $7.2 million last year, reflecting the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.